198 related articles for article (PubMed ID: 18814280)
41. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
42. Cyclooxygenase 2-dependent regulation of antitumor immunity in lung cancer.
Sharma S; Huang M; Dohadwala M; Pold M; Batra RK; Dubinett SM
Methods Mol Med; 2003; 75():723-36. PubMed ID: 12407775
[No Abstract] [Full Text] [Related]
43. 6-(1-Oxobutyl)-5,8-dimethoxy-1,4-naphthoquinone inhibits lewis lung cancer by antiangiogenesis and apoptosis.
Lee HJ; Lee HJ; Song GY; Li G; Lee JH; Lü J; Kim SH
Int J Cancer; 2007 Jun; 120(11):2481-90. PubMed ID: 17311288
[TBL] [Abstract][Full Text] [Related]
44. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
[TBL] [Abstract][Full Text] [Related]
45. Presence of membrane-bound TGF-beta1 and its regulation by IL-2-activated immune cell-derived IFN-gamma in head and neck squamous cell carcinoma cell lines.
Ahn YO; Lee JC; Sung MW; Heo DS
J Immunol; 2009 May; 182(10):6114-20. PubMed ID: 19414763
[TBL] [Abstract][Full Text] [Related]
46. Expression of the chemokine receptor CCR6 in the Lewis lung carcinoma (LLC) cell line reduces its metastatic potential in vivo.
Sutherland A; Mirjolet JF; Maho A; Parmentier M
Cancer Gene Ther; 2007 Oct; 14(10):847-57. PubMed ID: 17599091
[TBL] [Abstract][Full Text] [Related]
47. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM
Cancer Res; 2005 Jun; 65(12):5211-20. PubMed ID: 15958566
[TBL] [Abstract][Full Text] [Related]
48. [Study on the mechanism of polypeptide extract from scorpion venom to promote the restraint of cyclophosphamide on Lewis lung cancer].
Ning YN; Zhang WD; Wu LC
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Apr; 32(4):537-42. PubMed ID: 22803439
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of urokinase activity reduces primary tumor growth and metastasis formation in a murine lung carcinoma model.
Henneke I; Greschus S; Savai R; Korfei M; Markart P; Mahavadi P; Schermuly RT; Wygrecka M; Stürzebecher J; Seeger W; Günther A; Ruppert C
Am J Respir Crit Care Med; 2010 Mar; 181(6):611-9. PubMed ID: 20056905
[TBL] [Abstract][Full Text] [Related]
50. Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells.
Kato M; Nakamura Y; Suda T; Ozawa Y; Inui N; Seo N; Nagata T; Koide Y; Kalinski P; Nakamura H; Chida K
Cancer Immunol Immunother; 2011 Jul; 60(7):1029-38. PubMed ID: 21519830
[TBL] [Abstract][Full Text] [Related]
51. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
52. Fusion with human lung cancer cells elongates the life span of human umbilical endothelial cells and enhances the anti-tumor immunity.
Mu X; Fang C; Zhou J; Xi Y; Zhang L; Wei Y; Yi T; Wu Y; Zhao X
J Cancer Res Clin Oncol; 2016 Jan; 142(1):111-23. PubMed ID: 26139353
[TBL] [Abstract][Full Text] [Related]
53. Using adenovirus armed short hairpin RNA targeting transforming growth factor β1 inhibits melanoma growth and metastasis in an ex vivo animal model.
Tai KF; Wang CH
Ann Plast Surg; 2013 Dec; 71 Suppl 1():S75-81. PubMed ID: 24284745
[TBL] [Abstract][Full Text] [Related]
54. CXCL7-induced macrophage infiltration in lung tumor is independent of CXCR2 expression: CXCL7-induced macrophage chemotaxis in LLC tumors.
Unver N; Esendagli G; Yilmaz G; Guc D
Cytokine; 2015 Oct; 75(2):330-7. PubMed ID: 26233476
[TBL] [Abstract][Full Text] [Related]
55. Aspirin reduces lung cancer metastasis to regional lymph nodes.
Ogawa F; Amano H; Ito Y; Matsui Y; Hosono K; Kitasato H; Satoh Y; Majima M
Biomed Pharmacother; 2014 Feb; 68(1):79-86. PubMed ID: 24331369
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of Lewis lung carcinoma growth by Toxoplasma gondii through induction of Th1 immune responses and inhibition of angiogenesis.
Kim JO; Jung SS; Kim SY; Kim TY; Shin DW; Lee JH; Lee YH
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S38-46. PubMed ID: 17923753
[TBL] [Abstract][Full Text] [Related]
57. Specific overexpression of 15-lipoxygenase in endothelial cells promotes cancer cell death in an in vivo Lewis lung carcinoma mouse model.
Sultan M; Ben-Shushan D; Peled M; Kamari Y; Isman S; Barshack I; Kuban RJ; Kühn H; Harats D; Shaish A
Adv Med Sci; 2020 Mar; 65(1):111-119. PubMed ID: 31923770
[TBL] [Abstract][Full Text] [Related]
58. Additive effects of ulinastatin and docetaxel on growth of breast cancer xenograft in nude mice and expression of PGE2, IL-10, and IL-2 in primary breast cancer cells.
Zhong B; Shen H; Sun X; Wang H; Zhang Y; Sun Z
Cancer Biother Radiopharm; 2012 May; 27(4):252-8. PubMed ID: 22594905
[TBL] [Abstract][Full Text] [Related]
59. Ethanol supports macrophage recruitment and reinforces invasion and migration of Lewis lung carcinoma.
Yu K; Yang J; Wang F; Chen L; Lu Y; Luo J; Wang S
Alcohol Clin Exp Res; 2014 Oct; 38(10):2597-606. PubMed ID: 25346504
[TBL] [Abstract][Full Text] [Related]
60. MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis.
Chou CH; Teng CM; Tzen KY; Chang YC; Chen JH; Cheng JC
Oncogene; 2012 Jan; 31(4):458-68. PubMed ID: 21706046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
